Sorry, you need to enable JavaScript to visit this website.
Home Science Areas of Innovation Maternal Immunization

Maternal Immunization

What is Maternal Immunization?

Maternal immunization is a tool to help pregnant people pass on disease-specific antibodies to the fetus during the second and early third trimesters, helping to protect the infant during the most vulnerable time of life—the first six months.1

doctor-checking-a-newborn-royalty-free-image

Enhancing the Power of Maternally Derived Immunity

The immune systems of infants are often not strong enough to protect against infections. Direct active immunization (vaccination provided to the child) is not an option for some life-threatening infectious diseases because infant immune systems are not fully developed and when available, multiple doses are typically required.2 Maternal immunity is a natural phenomenon by which pregnant people provide protection to their vulnerable and growing babies by transferring antibodies through the placenta.1

In order to provide protection, however, enough antibodies need to be passed to the baby. This means that higher antibody levels in the gestational parent, are more likely to lead to increased levels of antibodies in the developing fetus, which can help protect the infant after birth. Pregnant people can acquire high levels of antibodies either through a recent exposure to infectious disease or through vaccination.3

Maternal vaccination can help enhance existing maternal immunity by ensuring that pregnant people have enough antibodies to transfer to their babies. Additionally, vaccinated pregnant people produce vaccine-specific antibodies that can help better protect infants against specific infections.3 Vaccines against tetanus, influenza, and pertussis have been used during pregnancy for many years to enhance maternal immunity and help protect infants.3

female virologist examining test tube

Pfizer’s Maternal Vaccine Candidates: Furthering a Legacy of Scientific Excellence

Building on decades of expertise and knowledge in pioneering vaccines, Pfizer is developing potential maternal immunizations for respiratory syncytial virus (RSV) and Group B streptococcus (GBS), two leading causes of infant morbidity and mortality worldwide that have limited treatment and preventative approaches.

Currently, there is no specific antiviral treatment for RSV, a contagious virus and a common cause of respiratory illness, and the medical world is limited to offering only supportive care for those with the illness, which can treat symptoms but not prevent disease.4 GBS, a common bacterium (an organism that can cause disease), can cause potentially devastating diseases in infants when gestational individuals who carry the GBS bacteria pass them on to their newborns during labor and birth.5 Prevention of invasive infant GBS disease relies upon screening and administration of antibiotics during delivery (known as intrapartum antibiotics or IAP), though many countries do not have the resources to implement IAP and IAP policies are not 100% effective at preventing invasive GBS disease even when correctly implemented.6,7

Strategic Partnerships to Deliver Life Changing Vaccines

Pfizer’s maternal immunization efforts, including our focus on RSV and GBS, align with our broader commitment to partner with the global health community, including public-private partnerships that may help accelerate global access to our vaccines in the world's poorest countries.

Our longstanding partnership with the Bill and Melinda Gates Foundation, with respect to our maternal immunization program, includes grants to support the continued development of certain aspects of our GBS and RSV vaccine candidates, and accessibility of these vaccine candidates, if approved, for those who are pregnant and living in lower-income countries where prevalence of these potentially devastating infections is higher.

What You Need to Know About Maternal Immunization

  • The immune systems of infants often are not yet strong enough to defend against all infections. Direct active immunization (vaccination provided to the child) is not an option for some life-threatening infectious diseases because infant immune systems are not yet fully developed, and when available, multiple doses are typically required.2 Consequently, although an infant’s immune system can fight off most infections, some can be serious or fatal.

  • To compensate for infants’ still-developing immune systems, nature devised a temporary defense mechanism to help infants fight off infections. Starting in the second trimester, and peaking during the third trimester of pregnancy, antibodies pass from the gestational parent to the growing fetus through the placenta. These maternal antibodies are highest in the baby at the time of birth and then gradually decline over the next 6 to 12 months as the baby’s own immune system matures.1 In addition, after birth, antibodies can also be passed to the child through breastfeeding.8 Maternal antibodies can help infants to fight off infections during their most vulnerable time of life—the first six months.1

    To provide protection, however, enough antibodies need to be passed to the fetus. This means that higher antibody levels in the gestational parent, are more likely to lead to increased levels of antibodies in the developing fetus. Those who are pregnant can acquire high levels of antibodies either through a recent exposure to infectious disease or through vaccination. Maternal vaccination may help ensure that those who are pregnant have enough antibodies available to transfer to their babies in hopes of decreasing the infant’s risk of disease and death.3

  • Antibodies passed to infants during pregnancy are believed to provide immunity until around six months of age, when they’re most vulnerable to infections. Breast feeding can extend a baby’s ability to fight infection by strengthening immunity.9

  • The safety of certain vaccines during pregnancy has been studied extensively in multiple randomized clinical trials and observational studies. Vaccines like tetanus, Tdap and influenza have been administered to pregnant people around the world, and currently, the WHO recommends three maternal immunization strategies:10

    1. Influenza vaccine, which The Vaccine Alliance (GAVI) estimates could prevent 45 deaths per 100,000 people vaccinated
    2. Maternal tetanus vaccine, which has reduced neonatal tetanus by an estimated 94%
    3. The Tdap vaccine, which is thought to be the most cost-effective strategy for reducing neonatal and infant pertussis

    In the U.S., the Centers for Disease Control and Prevention (CDC) recommends that pregnant people in their third trimester get the Tdap vaccine to help protect their babies from whooping cough (pertussis). The CDC also advises that pregnant people get the influenza vaccine to help protect themselves and their babies from flu-related complications.11 Additionally, the CDC recommends people who are pregnant receive a COVID-19 vaccine as it can help protect them from potentially serious illness caused by the virus.12

  • To reduce the global disease burden in young infants, WHO, the U.S. Food and Drug Administration (FDA), and other regulatory agencies, along with The Bill and Melinda Gates Foundation (BMGF), have recognized the importance of developing vaccines specifically for those who are pregnant.

    Particular focus is now being placed on developing vaccines against respiratory syncytial virus (RSV), a virus-causing respiratory illness that can be devastating,4 particularly for infants in the first few months of life, and Group B streptococcus (GBS), a bacterial illness that can strike within just a few hours or days after birth.

    Pfizer’s Vaccine Research and Development (R&D) team is actively and passionately working on developing potential maternal vaccines for RSV and GBS, with the goal of reducing the global disease burden of these pathogens.

Related Articles

Four Things to Know About Vaccination During Pregnancy

Maternal vaccines enhance the natural level of antibodies in pregnant women, which are then passed to babies in the womb to protect them against infections. Here are four things you need to know about vaccination during pregnancy. 1. Babies are very vulnerable in the first few weeks of life The risk...

Four Things to Know About Vaccination During Pregnancy
What's Next? Coronavirus, Disease X, Maternal & Adult Immunization

On Episode 8 of podcast series "The Antigen:" What's Next? Coronavirus, Disease X, Maternal & Adult Immunization. Visit our "The Antigen" podcast page to listen in.

What's Next? Coronavirus, Disease X, Maternal & Adult Immunization
How Maternal Immunization Helps Protect Babies From Infections

You could say the instinct to protect a baby starts when it’s in the womb. Starting in the second trimester of pregnancy, a pregnant woman passes important disease-fighting molecules called immunoglobulin G, or IgG, through the placenta to her fetus. As the pregnancy continues, this sharing of...

How Maternal Immunization Helps Protect Babies From Infections
Group B Strep: A Dangerous Infection in Infants and Adults

Despite advances in treatment and prevention, Group B strep continues to be the leading cause of dangerous infections in newborns, pregnant mothers and adults.   An estimated 10% – 30% of pregnant women in the U.S. carry Group B streptococcus (GBS), bacteria that live in the intestine, vagina...

Group B Strep: A Dangerous Infection in Infants and Adults
Next-Gen Scientific Changemakers: An Infectious Disease Specialist on a Mission to Develop Vaccines

Soldiers, firefighters and police officers likely come to mind when you think of professions that require a good amount of courage. But Iona Munjal, a physician and pediatric infectious disease specialist who helps design and oversee vaccine clinical trials for Pfizer, argues scientists should be...

Next-Gen Scientific Changemakers: An Infectious Disease Specialist on a Mission to Develop Vaccines
This Scientist's Life: Judith Absalon

Meet Judith Absalon, a Senior Director in Vaccines Clinical Research at Pfizer’s Pearl River, N.Y., research site. As a global clinical lead, she’s the head doctor that oversees the clinical trial process when a new vaccine candidate is tested in people.   Clinical trials are rooted in the...

This Scientist's Life: Judith Absalon
New Podcast, ‘The Antigen,’ Takes a Deep Dive into the Story of Vaccines

When we decided to create a podcast about vaccines, Yasmeen Agosti, MD was a natural choice to host . For many years, vaccines have been an enormous part of Agosti’s life, first as a pediatrician, now as the global medical affairs lead for viral vaccines at Pfizer. In our new audio series, called...

New Podcast, ‘The Antigen,’ Takes a Deep Dive into the Story of Vaccines
Advances in Cytomegalovirus Vaccine Development

While it may not be a household name, cytomegalovirus (CMV), a member of the herpes virus family, is incredibly common—many people acquire it as toddlers or adolescents, and a majority are infected by adulthood.1 In most people, CMV is harmless and causes no or few symptoms.2 However, it can pose...

Advances in Cytomegalovirus Vaccine Development
    1. Faucette A, et al. Immunization of pregnant women: Future of early infant protection. Hum Vaccin Immunother. 2015;11(11):2549-2555. doi:10.1080/21645515.2015.1070984.
    2. Bergin N, et al. Maternal Vaccination as an Essential Component of Life-Course Immunization and Its Contribution to Preventive Neonatology. Int J Environ Res Public Health. 2018;15(5):847. doi:10.3390/ijerph15050847.
    3. Vojtek I, et al. Maternal immunization: where are we now and how to move forward?, Ann Med. 2018;50(3):193-208. doi:10.1080/07853890.2017.1421320.
    4. Symptoms & Care. Centers for Disease Control and Prevention. Updated October 24, 2022. Accessed March 29, 2023. https://www.cdc.gov/rsv/about/symptoms.html.
    5. Kwatra G, et al. Prevalence of maternal colonization with group b streptococcus: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(9):1076-1084. doi:10.1016/S1473-3099(16)30055-X.
    6. Le Doare K, O'Driscoll M, Turner K, et al. Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review. Clin Infect Dis. 2017;65(2):S143-S151. doi:10.1093/cid/cix654.
    7. Patras KA, Nizet V. Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches. Front Pediatr. 2018;6:27. doi:10.3389/fped.2018.00027.
    8. Breastfeeding Benefits Both Baby and Mom. Centers for Disease Control and Prevention. Updated July 27, 2021. Accessed March 9, 2023. https://www.cdc.gov/nccdphp/dnpao/features/breastfeeding-benefits/index.html.
    9. Flor M., Jamison D., Maternal Immunization. Obstet Gynecol. 2019 Apr;133(4):739-753. doi:10.1097/AOG.0000000000003161.
    10. Williams AL, et al. Maternal vaccine knowledge in low-and middle-income countries-and why it matters. Hum Vaccin Immunother. 2019;15(2):283-286. doi:10.1080/21645515.2018.1526589.
    11. Vaccines During Pregnancy FAQs. Centers for Disease Control and Prevention. Updated August 24, 2020. Accessed March 29, 2023. https://www.cdc.gov/vaccinesafety/concerns/vaccines-during-pregnancy.html#Safe.
    12. COVID-19 Vaccines While Pregnant or Breastfeeding. Centers for Disease Control and Prevention. Updated October 20, 2022. Accessed March 29, 2023. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html#:~:text=CDC%20recommends%20COVID%2D19%20vaccines,is%20time%20to%20get%20one.